Biomark Diagnostics Overview

  • Founded
  • 2007

Founded
  • Status
  • Public

  • Stock Symbol
  • BUX

Stock Symbol
  • Investments
  • 3

  • Share Price
  • $0.23

  • (As of Wednesday Closing)

Biomark Diagnostics General Information

Description

Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced-stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Healthcare Technology Systems
Stock Exchange
CNQ
Primary Office
  • 3851 Shell Road
  • Suite 130
  • Richmond, British Columbia V6X 2W2
  • Canada
+1 (604) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomark Diagnostics Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.23 $0.23 $0.14 - $0.24 $17.6M 78M 24.7K -$0.02

Biomark Diagnostics Financials Summary

In Thousands,
USD
TTM 31-Dec-2021 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019
EV 16,306 24,411 8,623 3,099
Revenue 16 0 198 0
EBITDA (984) (813) (903) (416)
Net Income (1,043) (827) (913) (416)
Total Assets 1,091 755 449 26
Total Debt 761 95 6 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biomark Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biomark Diagnostics‘s full profile, request access.

Request a free trial

Biomark Diagnostics Executive Team (6)

Name Title Board Seat Contact Info
Rashid Ahmed Founder & Chief Executive Officer
Thomas Malcolm President & Chief Scientific Officer
Gina Huang Chief Financial Officer and Project Director
Brian Cheng Chief Technical Officer
Jeff Haince General Manager & Chief Scientific Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Biomark Diagnostics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biomark Diagnostics‘s full profile, request access.

Request a free trial

Biomark Diagnostics Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 30-Oct-2014 0000000000 Holding Companies
00000000 0000 01-Oct-2014 0000000000 Educational Software
Sierra Coastal Partners 14-Mar-2013 Merger/Acquisition Investment Banks
To view Biomark Diagnostics’s complete acquisitions history, request access »